Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol desmolase (CYP11A1) and Mycobacterium tuberculosis co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Vitamin D |
Click to Show/Hide the Detail |
Drug ID |
DR1700
Drug Info
|
Interaction Mechanism |
Human Cholesterol desmolase (CYP11A1) and Mycobacterium tuberculosis co-metabolize the drug Vitamin D, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
Mycolicibacterium smegmatis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol desmolase (CYP11A1) and Mycolicibacterium smegmatis co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [5] |
Bacteria: Firmicutes |
Eubacterium coprostanoligenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol desmolase (CYP11A1) and Eubacterium coprostanoligenes co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
|
|
|
|
|
|